Diversity, Equity, And Inclusion (Dei) Quotient in The Age of Crispr-Cas 9: A Speculative Spectrum of Argumentation
Copyright policy )Diversity, Equity, And Inclusion (Dei) Quotient in The Age of Crispr-Cas 9: A Speculative Spectrum of Argumentation
The advent of CRISPR-Cas9 gene-editing technology has sparked a complex discourse on diversity, equity, and inclusion (DEI). While it could potentially eradicate genetic disorders affecting marginalized groups, concerns arise regarding ethical implications, eugenics, exacerbating biases, and socioeconomic divides. One salient aspect of this discourse pertains to the ethical considerations surrounding using CRISPR-Cas9 for germline editing, which could theoretically eradicate genetic disorders disproportionately affecting specific populations. Proponents argue it could foster inclusivity through personalized therapies for underrepresented populations, though met with skepticism. This revolutionary tool necessitates critically examining its ethical, socioeconomic, and governance ramifications.
- University of Louisville United States
- North Dakota State University United States
selected citations These citations are derived from selected sources.This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).0 popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network.Average influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).Average impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network.Average
Citations provided by BIP!Popularity provided by BIP!